Morimoto Yasutsugu, Kureishi-Bando Yasuko, Murohara Toyoaki
Department of Cardiology, Nagoya University Graduate School of Medicine.
Clin Calcium. 2010 Jan;20(1):69-75.
Ample evidence has demonstrated that calcium channel blockers (CCBs) exert pleiotropic effects on vasculature, leading to restoring endothelial dysfunction and suppressing progression of atherosclerosis both in experimental and clinical settings. CCBs protect vasculature by various antioxidative mechanisms as follows : stimulating endothelial NO production and/or restoring decline in circulating adiponectin and HDL level. Moreover, CCBs has been also demonstrated to enhance circulating endothelial progenitor cell level, of which has been known to correlate to endothelial function. through its antioxidative property. Accordingly, these evidences suggest that CCB could be expected as another antiatherosclerotic remedy in patient population.